241 results
8-K
EX-10.1
BLFS
Biolife Solutions Inc
23 Apr 24
Entry into a Material Definitive Agreement
5:27pm
to fraud may be made at any time following the Closing Date. (b) Notwithstanding anything to the contrary, the Buyer Indemnitees shall not be entitled … to Sections 8.1(b), 8.1(c), 8.1(d), 8.1(e), 8.1(f), 8.1(g), 8.1(h), and/or 8.1(i) or in the case of fraud. (c) The maximum liability of Seller under
8-K
EX-2.1
BLFS
Biolife Solutions Inc
23 Apr 24
Entry into a Material Definitive Agreement
5:27pm
to fraud may be made at any time following the Closing Date. (b) Notwithstanding anything to the contrary, the Buyer Indemnitees shall not be entitled … to Sections 8.1(b), 8.1(c), 8.1(d), 8.1(e), 8.1(f), 8.1(g), 8.1(h), and/or 8.1(i) or in the case of fraud. (c) The maximum liability of Seller under
D
rrx4h5wyiyc55d3
27 Oct 23
$10.37 mm in equity, sold $10.37 mm, 1 investor
5:17pm
8-K
EX-10.1
f1oiywnsnjb zkqh
23 Oct 23
BioLife Solutions Announces Leadership Transitions & Preliminary Third Quarter Revenue with Updated Outlook for 2023
4:41pm
S-8
EX-4.1
qt232p
16 Aug 23
Registration of securities for employees
1:55pm